567 Results

People

  1. Motzer
    Motzer
  2. Horwitz
    Horwitz
  3. Riely
    Riely
  4. Zelenetz
    Zelenetz
  5. Kris
    Kris
  6. Postow
    Postow
  7. Rusch
    Rusch
  8. Wolchok
    Wolchok
  9. Bains
    Bains
  10. Giralt
    Giralt

Groups

  1. Department of Medicine (349)
  2. Solid Tumor Oncology Division (186)
  3. Hematologic Malignancies, Division of (140)
  4. Center for Hematologic Malignancies (120)
  5. Survivorship Research (74)
  6. Surgery (72)
  7. Division of Subspecialty Medicine (66)
  8. GSK Faculty (53)
  9. Thoracic Oncology (53)
  10. Lymphoma (48)
  1. "pneumonia"
Formats
  1. Journal Article (509)
  2. Review (36)
  3. Research Letter (5)
  4. Book Section (4)
  5. Editorial (4)
  6. Correspondence (3)
  7. Guidelines (3)
  8. Conference Paper (1)
  9. Meeting Abstract (1)
  10. Miscellaneous (1)
Groups
  1. Department of Medicine (349)
  2. Solid Tumor Oncology Division (186)
  3. Hematologic Malignancies, Division of (140)
  4. Center for Hematologic Malignancies (120)
  5. Survivorship Research (74)
  6. Surgery (72)

More Groups

People
  1. Robert Motzer (24)
  2. Jedd Wolchok (16)
  3. Steven Horwitz (15)
  4. Andrew Zelenetz (14)
  5. Gregory Riely (14)
  6. Mark Kris (12)

More People

Years
  1. 2025 (27)
  2. 2024 (54)
  3. 2023 (48)
  4. 2022 (24)
  5. 2021 (20)
  6. 2020 (40)

More Years

Publications
  1. Journal of Clinical Oncology (34)
  2. Lancet Oncology (23)
  3. Cancer (17)
  4. Blood (16)
  5. Journal of Thoracic Oncology (14)
  6. Blood Advances (13)

More Publications

Publishers
  1. Elsevier Inc. (105)
  2. Elsevier Science, Inc. (49)
  3. Springer (36)
  4. American Society of Clinical Oncology (35)
  5. Nature Publishing Group (35)
  6. Oxford University Press (34)

More Publishers

Results (567)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • (99m)Tc-Vitamin C SPECT/CT imaging in SARS-CoV-2 associated pneumonia
    Journal Article

    Sayman, H. B.; Toplutas, K. N.; Tunick, J.; Aras, O.
    Nuclear Medicine Review (2022)

    Fulltext@MSK | Save
  • Telaglenastat plus everolimus in advanced renal cell carcinoma: A randomized, double-blinded, placebo-controlled, phase II ENTRATA trial
    Journal Article

    Lee, C. H.; Motzer, R.; Emamekhoo, H.; Matrana, M.; Percent, I.; Hsieh, J. J.; Hussain, A.; Vaishampayan, U.; Liu, S.; McCune, S.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Algorithmic approach to the diagnosis of organizing pneumonia: A correlation of clinical, radiologic, and pathologic features
    Review

    Cherian, S. V.; Patel, D.; Machnicki, S.; Naidich, D.; Stover, D.; Travis, W. D.; Brown, K. K.; Naidich, J. J.; Mahajan, A.; Esposito, M.; more...
    Chest (2022)

    Fulltext@MSK | Save
  • Triplet therapy, transplantation, and maintenance until progression in myeloma
    Journal Article

    Richardson, P. G.; Jacobus, S. J.; Weller, E. A.; Hassoun, H.; Lonial, S.; Raje, N. S.; Medvedova, E.; McCarthy, P. L.; Libby, E. N.; Voorhees, P. M.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • Multifocal and pathologically-confirmed brain metastasis complete response to trastuzumab deruxtecan
    Journal Article

    Moss, N. S.; Tosi, U.; Santomasso, B. D.; Beal, K.; Modi, S.
    CNS Oncology (2022)

    Fulltext@MSK | Save
  • Robot-assisted minimally invasive esophagectomy versus open esophagectomy for esophageal Cancer: A systematic review and meta-analysis
    Review

    Esagian, S. M.; Ziogas, I. A.; Skarentzos, K.; Katsaros, I.; Tsoulfas, G.; Molena, D.; Karamouzis, M. V.; Rouvelas, I.; Nilsson, M.; Schizas, D.
    Cancers (2022)

    Fulltext@MSK | Save
  • Neoadjuvant systemic therapy (NAST) in patients with melanoma: Surgical considerations by the International Neoadjuvant Melanoma Consortium (INMC)
    Guidelines

    van Akkooi, A. C. J.; Hieken, T. J.; Burton, E. M.; Ariyan, C.; Ascierto, P. A.; Asero, S. V. M. A.; Blank, C. U.; Block, M. S.; Boland, G. M.; Caraco, C.; more...
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • EZH2 inhibitor tazemetostat in patients with relapsed or refractory, BAP1-inactivated malignant pleural mesothelioma: A multicentre, open-label, phase 2 study
    Journal Article

    Zauderer, M. G.; Szlosarek, P. W.; Le Moulec, S.; Popat, S.; Taylor, P.; Planchard, D.; Scherpereel, A.; Koczywas, M.; Forster, M.; Cameron, R. B.; more...
    Lancet Oncology (2022)

    Fulltext@MSK | Save
  • A phase I study investigating AZD8186, a potent and selective inhibitor of PI3Kβ/δ, in patients with advanced solid tumors
    Journal Article

    Choudhury, A. D.; Higano, C. S.; de Bono, J. S.; Cook, N.; Rathkopf, D. E.; Wisinski, K. B.; Martin-Liberal, J.; Linch, M.; Heath, E. I.; Baird, R. D.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)–related interstitial lung disease/pneumonitis—Focus on proactive monitoring, diagnosis, and management
    Review

    Swain, S. M.; Nishino, M.; Lancaster, L. H.; Li, B. T.; Nicholson, A. G.; Bartholmai, B. J.; Naidoo, J.; Schumacher-Wulf, E.; Shitara, K.; Tsurutani, J.; more...
    Cancer Treatment Reviews (2022)

    Fulltext@MSK | Save